Completed PHASE3 INTERVENTIONAL 3-arm NCT00145769

A Randomised Trial of Preoperative Radiotherapy for Stage T3 Adenocarcinoma of Rectum

Sponsor: Australasian Gastro-Intestinal Trials Group

Interventions Concurrent Chemotherapy Initial Surgery Long Course Adjuvant Chemotherapy Long Course Radiotherapy Short Course Adjuvent Chemotherapy Short Course Radiotherapy

Updated 5 times since 2017 Last updated: Aug 7, 2013 Started: Jul 31, 2001 Primary completion: Jun 30, 2009 Completion: May 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00145769, this PHASE3 trial focuses on Adenocarcinoma of Rectum and remains completed. Sponsored by Australasian Gastro-Intestinal Trials Group, it has been updated 5 times since 2001, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jul 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Australasian Gastro-Intestinal Trials Group
Colorectal Surgical Society of Australasia (CSSA)
Royal Australasian College of Surgeons (RACS)
Trans Tasman Radiation Oncology Group

Data source: Trans Tasman Radiation Oncology Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Adelaide, Australia , Auckland, New Zealand , Bendigo, Australia , Box Hill, Australia , Brisbane, Australia , Campbelltown, Australia , Camperdown, Australia , East Bentleigh, Australia , East Melbourne, Australia , Fitzroy, Australia and 24 more locations